$10.51 -0.23 (-2.14%)
11/27/2009 1:00 PM

InterMune, Inc. (ITMN)

CAPS Rating: 2 out of 5

The Company is a biotech company focused on developing and commercializing innovative therapies in pulmonology and hepatology.

Featured Broker Partners